Alector (ALEC) Capital Expenditures (2018 - 2026)
Alector's (ALEC) quarterly Capital Expenditures came in at $30000.0 in Q1 2026, up 50.0% year-on-year from $20000.0 in Q1 2025, and down 26.83% on a QoQ basis from $41000.0 in Q4 2025.
Alector (ALEC) Capital Expenditures (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Capital Expenditures data on file, last reported at $30000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 50.0% year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $51000.0, a 93.13% decrease from a year earlier, with the FY2025 full-year figure at $41000.0, down 96.73% from the prior year.
- Capital Expenditures for Q1 2026 stood at $30000.0, down from $41000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for ALEC reached as high as $1.9 million in Q3 2022 and fell as low as -$2.9 million in Q4 2022.
- Historically, Capital Expenditures has averaged $262500.0 across 5 years, with a median of $321000.0 in 2023.
- On a YoY basis, Capital Expenditures climbed as much as 1809.82% in 2022 and fell as far as 709.38% in 2022.
- Year by year, Capital Expenditures stood at -$2.9 million in 2022, then jumped by 108.15% to $233000.0 in 2023, then jumped by 427.04% to $1.2 million in 2024, then tumbled by 96.66% to $41000.0 in 2025, then retreated by 26.83% to $30000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $30000.0 in Q1 2026, $41000.0 in Q4 2025, and -$20000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | -843,000.00 |
| Sep 30, 2024 | -843,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 233,000.00 |
| Dec 31, 2023 | 233,000.00 |
| Sep 30, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.40 Mn |